Why the study?
Can a novel method measure absolute coronary blood flow and microvascular resistance alongside FFR in patients with ischaemic heart disease?
Can a novel method measure absolute coronary blood flow and microvascular resistance alongside FFR in patients with ischaemic heart disease?
A novel method allows for the measurement of absolute coronary flow and microvascular resistance during routine catheterization without extra equipment or drugs, potentially improving patient stratification.
Answers are grounded in this paper and cite their sources.
May enable routine discrimination of epicardial versus microvascular disease; leaves open whether this improves risk stratification or outcomes.
Absolute coronary flow and MVR can be determined alongside FFR, in absolute units, during routine catheter laboratory assessment, without the need for additional catheters, wires or drug infusions. Using this novel method, epicardial and microvascular disease can be discriminated and quantified. This comprehensive coronary physiological assessment may enable a new level of patient stratification and management.
No takes yet. Share an insight, caveat, or question.
Morris et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: